(146 days)
No
The summary does not mention AI, ML, or any related concepts like deep learning, neural networks, or algorithms that learn from data. The description focuses on standard ultrasound imaging capabilities and features.
No
The device is described as an imaging system used for visualization and assessment of anatomical structures and blood flow, not for providing therapy.
Yes
The device is described as an ultrasound system intended for "ultrasound imaging and fluid flow analysis" and for "capturing detailed anatomical structures and evaluating blood flow patterns." This capability to visualize internal structures and processes for assessment makes it a diagnostic device. Furthermore, its predicate device, K150204, is explicitly named "DC-70/DC-70T/DC-70 PRO/DC-70 EXP Diagnostic Ultrasound Systems," reinforcing its diagnostic purpose.
No
The device description explicitly states it consists of a "handheld ultrasound main unit and software," indicating a hardware component is integral to the system.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- Device Function: The description clearly states that this device is an ultrasound system. Ultrasound uses sound waves to create images of internal body structures. It does not analyze samples taken from the body.
- Intended Use: The intended use is for "ultrasound imaging and fluid flow analysis" of various anatomical sites within the body.
Therefore, this device falls under the category of medical imaging equipment, not in vitro diagnostics.
N/A
Intended Use / Indications for Use
The Portable Digital Color Doppler Ultrasound System is intended for ultrasound imaging in B (2D), Color Doppler and Pulsed Wave imaging modes. It is indicated for ultrasound imaging and fluid flow analysis in the following applications: Abdominal, Small Organ, Musculoskeletal, Peripheral Vessel, Urology, and Carotid. The Portable Digital Color Doppler Ultrasound System is intended for use in environments where healthcare is provided by appropriately trained and qualified healthcare professionals.
Product codes (comma separated list FDA assigned to the subject device)
IYN, IYO, ITX
Device Description
The Portable Digital Color Doppler Ultrasound System is a portable, general-purpose, software-controlled ultrasound system. It consists of a handheld ultrasound main unit and software. The system is engineered to produce real-time ultrasound images, with an emphasis on capturing detailed anatomical structures and evaluating blood flow patterns using color Doppler technology. It includes features for measurements, image storage and review, as well as printing and recording capabilities. This portable system enables point-of-care ultrasound applications, providing healthcare professionals with a convenient way to visualize anatomical structures and assess blood flow dynamics.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Ultrasound
Anatomical Site
Abdominal, Small Organ, Musculoskeletal, Peripheral Vessel, Urology, Carotid.
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Healthcare professionals / environments where healthcare is provided by appropriately trained and qualified healthcare professionals.
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Portable Digital Color Doppler Ultrasound System has passed testings according to:
- ANSI AAM ES60601-1:2005/R12012 & A1:2010/R)2012 & A2:2010/RJ2012 (Cons. Text) Incl. AMD2:2021), Medical electrical equipment - Part 1: Geneal requirements for basic safety and essential performance (IEC 60601-1:2005, MOD) [Including Amendment 2 (2021)]:
- IEC 6661-1-2 Editor 4.1 2020-09 CONSOLIDATED VERSION, Medical electrical coupments for basic safety and essertail performance -Collateral Standard: Electromagnetic disturbances - Requirements and tests;
- IEC TR 60601-4-2 Editor 1.0 2016-05, Medical equipment - Part 4-2: Guidance and interpretation - Electromagencie immunity performance of medical clectrical equipment and medical electrical systems;
- IEC 60601-1-6 Editor 3.2 2020-07 CONSOLDATED VERSION. Medical electrical coursent - Part 1-6: Galety and esserial performance-Collateral standard: Usability;
- IEC 62366-1 Edition 1.1 2020-06 CONSOLIDATED VERSION, Medical devices - Part 1: Application of usability engineering to medical devices;
- IEC 6601-2-37 Edition 2.1 2015, Medical electrical equirements for the basic safety and essental performance of ultraonic medical diagnostic and monitoring equipment;
- IEC 623.9 Edition 2.1 2017-09 CONSOLIDATED VERSION, Ultrasoniss - Field characterization - Test methods for the mall nechanical indices related to medical diagnostic ultrasonic fields;
- NEMA UD 3-2004 (R2009), Standard for Real-Time Display of Thermal and Mechanical Acoustic Ultrasound Fourprent;
- IEC 62304 Edition 1.1 2015-06 CONSOLIDATED VERSION, Medical device software life cycle processes.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 892.1550 Ultrasonic pulsed doppler imaging system.
(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows the date October 24, 2024. The text is in a simple, sans-serif font. The date is written out in full, with the month, day, and year clearly visible. The text is centered and takes up most of the image.
Image /page/0/Picture/1 description: The image shows the logo of the U.S. Food and Drug Administration (FDA). The logo consists of two parts: the Department of Health and Human Services logo on the left and the FDA logo on the right. The FDA logo features the letters "FDA" in a blue square, followed by the words "U.S. FOOD & DRUG ADMINISTRATION" in blue text.
Telefield Medical Imaging (Shenzhen) Limited Dolly Xiong Regulatory Affairs Manager Room A614-A619, A701-A703, National Key Lab Platform Building No.1 Yuexing Second Road, Hi-tech Industrial Park, Nanshan Dist Shenzhen, Guangdong 518054 CHINA
Re: K241554
Trade/Device Name: Portable Digital Color Doppler Ultrasound System (SCN201D, SCN201L) Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic Pulsed Doppler Imaging System Regulatory Class: Class II Product Code: IYN. IYO. ITX Dated: May 10, 2024 Received: May 31, 2024
Dear Dolly Xiong:
We have reviewed your section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (the Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. Although this letter refers to your product as a device, please be aware that some cleared products may instead be combination products. The 510(k) Premarket Notification Database available at https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm identifies combination product submissions. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
1
Additional information about changes that may require a new premarket notification are provided in the FDA guidance documents entitled "Deciding When to Submit a 510(k) for a Change to an Existing Device" (https://www.fda.gov/media/99812/download) and "Deciding When to Submit a 510(k) for a Software Change to an Existing Device" (https://www.fda.gov/media/99785/download).
Your device is also subject to, among other requirements, the Quality System (OS) regulation (21 CFR Part 820), which includes, but is not limited to, 21 CFR 820.30, Design controls; 21 CFR 820.90, Nonconforming product; and 21 CFR 820.100, Corrective and preventive action. Please note that regardless of whether a change requires premarket review, the QS regulation requires device manufacturers to review and approve changes to device design and production (21 CFR 820.30 and 21 CFR 820.70) and document changes and approvals in the device master record (21 CFR 820.181).
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR Part 803) for devices or postmarketing safety reporting (21 CFR Part 4, Subpart B) for combination products (see https://www.fda.gov/combination-products/guidance-regulatory-information/postmarketing-safety-reportingcombination-products); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820) for devices or current good manufacturing practices (21 CFR Part 4, Subpart A) for combination products; and, if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR Parts 1000-1050.
All medical devices, including Class I and unclassified devices and combination product device constituent parts are required to be in compliance with the final Unique Device Identification System rule ("UDI Rule"). The UDI Rule requires, among other things, that a device bear a unique device identifier (UDI) on its label and package (21 CFR 801.20(a)) unless an exception or alternative applies (21 CFR 801.20(b)) and that the dates on the device label be formatted in accordance with 21 CFR 801.18. The UDI Rule (21 CFR 830.300(a) and 830.320(b)) also requires that certain information be submitted to the Global Unique Device Identification Database (GUDID) (21 CFR Part 830 Subpart E). For additional information on these requirements, please see the UDI System webpage at https://www.fda.gov/medical-device-advicecomprehensive-regulatory-assistance/unique-device-identification-system-udi-system.
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to https://www.fda.gov/medical-device-safety/medical-device-reportingmdr-how-report-medical-device-problems.
For comprehensive regulatory information about medical devices and radiation-emitting products, including information about labeling regulations, please see Device Advice (https://www.fda.gov/medicaldevices/device-advice-comprehensive-regulatory-assistance) and CDRH Learn (https://www.fda.gov/training-and-continuing-education/cdrh-learn). Additionally, you may contact the Division of Industry and Consumer Education (DICE) to ask a question about a specific regulatory topic. See the DICE website (https://www.fda.gov/medical-device-advice-comprehensive-regulatory
2
assistance/contact-us-division-industry-and-consumer-education-dice) for more information or contact DICE by email (DICE@fda.hhs.gov) or phone (1-800-638-2041 or 301-796-7100).
Sincerely,
YANNA S. KANG -S
Yanna Kang, Ph.D. Assistant Director Mammography and Ultrasound Team DHT8C: Division of Radiological Imaging and Radiation Therapy Devices OHT8: Office of Radiological Health Office of Product Evaluation and Quality Center for Devices and Radiological Health
3
Indications for Use
510(k) Number (if known) K241554
Device Name
Portable Digital Color Doppler Ultrasound System (SCN201D, SCN201L)
Indications for Use (Describe)
The Portable Digital Color Doppler Ultrasound System is intended for ultrasound imaging in B (2D), Color Doppler and Pulsed Wave imaging modes.
It is indicated for ultrasound imaging and fluid flow analysis in the following applications: Abdominal, Small Organ, Musculoskeletal, Peripheral Vessel, Urology, and Carotid.
The Portable Digital Color Doppler Ultrasound System is intended for use in environments where healthcare is provided by appropriately trained and qualified healthcare professionals.
Type of Use (Select one or both, as applicable)X Prescription Use (Part 21 CFR 801 Subpart D)
| Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
4
510(k) Summary
[As required by 21 CFR 807.92]
510(k) Number: K241554 Date: May 10th, 2024 Type of 510(k) Submission: Traditional 510(k) Basis for 510(k) Submission: New device Submitter: Telefield Medical Imaging (Shenzhen) Limited Room A614-A619, A701-A703, National Key Lab Platform Building, No.1 Yuexing Second Road, Hi-tech Industrial Park, Nanshan District, Shenzhen, Guangdong, People's Republic of China Tel: 86-755-83566313 Fax: 86-755-83571649 E-mail: info@scolioscan.com Contactor: Dolly Xiong Regulatory Affairs Manager E-mail: dolly.xiong@scolioscan.com Tel: 86-755-83566313 Fax: 86-755-83571649 2. Device Description Device Name: Portable Digital Color Doppler Ultrasound System SCN201D, SCN201L Model Name: Classification Name: Ultrasonic pulsed doppler imaging system Product Code: IYN, IYO, ITX Device Class: 2 Regulation Number: 21 CFR 892.1550, 21 CFR 892.1560, 21 CFR 892.1570 Review Panel: Radiology Indications for use: The Portable Digital Color Doppler Ultrasound System is intended for ultrasound imaging in B (2D), Color Doppler and Pulsed Wave imaging modes. It is indicated for ultrasound imaging and fluid flow analysis in the following applications: Abdominal, Small Organ, Musculoskeletal, Peripheral Vessel, Urology, and Carotid. The Portable Digital Color Doppler Ultrasound System is intended for use in environments where healthcare is provided by appropriately trained and qualified healthcare professionals. Device Description: The Portable Digital Color Doppler Ultrasound System is a portable, general-purpose, software-controlled ultrasound system. It consists of a handheld ultrasound main unit and software. The system is engineered to produce real-time ultrasound images, with an emphasis on capturing detailed anatomical structures and evaluating blood flow patterns using
1. Submission Information
5
color Doppler technology. It includes features for measurements, image storage and review, as well as printing and recording capabilities. This portable system enables point-of-care ultrasound applications, providing healthcare professionals with a convenient way to visualize anatomical structures and assess blood flow dynamics.
| Primary Predicate Device | Reference Device 1 | Reference Device 2 | |
|---|---|---|---|
| 510(k) Number | K150204 | K182845 | K201967 |
| Marketing | |||
| Clearance Date | 04/10/2015 | 12/27/2018 | 02/26/2021 |
| Product Name | DC-70/DC-70T/DC-70 | ||
| PRO/DC-70 EXP Diagnostic | |||
| Ultrasound Systems | minisono | Digital Color Doppler | |
| Palm Ultrasound System | |||
| (SonoEye P2) | |||
| Manufacturer | Shenzhen Mindray | ||
| Bio-medical Electronics Co., | |||
| LTD | ALPINION MEDICAL | ||
| SYSTEMS Co., Ltd. | CHISON Medical | ||
| Technologies Co., Ltd. |
3. Predicate Devices Identification
6
4. Substantially Equivalent Comparison
| Parameters | Proposed Device | Primary Predicate Device | Reference device 1 | Reference device 2 | Remark |
|---|---|---|---|---|---|
| 510(k) Number | K241554 | K150204 | K182845 | K201967 | -- |
| Marketing | |||||
| clearance date | No | April 10, 2015 | December 27, 2018 | February 26, 2021 | -- |
| Device Name | Portable Digital Color Doppler Ultrasound System | DC-70/DC-70T/DC-70 | |||
| PRO/DC-70 EXP Diagnostic | |||||
| Ultrasound Systems | minisono | Digital Color Doppler Palm | |||
| Ultrasound System | -- | ||||
| Model Name | SCN201D, SCN201L | DC-70/DC-70T/DC-70 | |||
| PRO/DC-70 EXP | minisono L3-12, minisono C1-6 | SonoEye P2 | -- | ||
| 510(k) Owner | Telefield Medical Imaging | ||||
| (Shenzhen) Limited | Shenzhen Mindray Bio-medical | ||||
| Electronics Co., LTD | ALPINION MEDICAL | ||||
| SYSTEMS Co., Ltd. | CHISON Medical Technologies | ||||
| Co., Ltd. | -- | ||||
| Regulation | |||||
| Number | 21 CFR 892.1550, 21 CFR | ||||
| 892.1560, 21 CFR 892.1570 | 21 CFR 892.1550, 21 CFR | ||||
| 892.1560, 21 CFR 892.1570, 21 | |||||
| CFR 892.2050 | 21 CFR 892.1550, 21 CFR | ||||
| 892.1560, 21 CFR 892.1570 | 21 CFR 892.1550, 21 CFR | ||||
| 892.1560, 21 CFR 892.1570 | Same | ||||
| Product Code | IYN, IYO, ITX | IYN, IYO, ITX, LLZ | IYN, IYO, ITX | IYN, IYO, ITX | Same |
| Device Class | 2 | 2 | 2 | 2 | Same |
| Review Panel | Radiology | Radiology | Radiology | Radiology | Same |
| Intended use | The Portable Digital Color | ||||
| Doppler Ultrasound System is | |||||
| intended for ultrasound imaging in | |||||
| B (2D), Color Doppler and Pulsed | |||||
| Wave imaging modes. | DC-70/DC-70T /DC-70 | ||||
| PRO/DC-70 EXP Diagnostic | |||||
| Ultrasound System is applicable | |||||
| for adults, pregnant women, | |||||
| pediatric patients and neonates. It | |||||
| is intended for use in fetal | The device is intended for use by a | ||||
| qualified physician for the | |||||
| evaluation of soft tissue and blood | |||||
| flow in the clinical applications; | |||||
| Fetal; Abdominal; Pediatric, Small | |||||
| Organ (breast, testes, thyroid) | The Digital Color Doppler Palm | ||||
| Ultrasound System is intended for | |||||
| diagnostic ultrasound imaging in | |||||
| B (2D), B/M, Color Doppler, | |||||
| Combined(B+Color), Pulsed Wave | |||||
| and Fusion Harmonic Imaging | Similar | ||||
| imaging and fluid flow analysis in | |||||
| the following applications: | |||||
| Abdominal, | |||||
| Small Organ, | |||||
| Musculoskeletal, | |||||
| Peripheral Vessel, Urology, and Carotid. | |||||
| The Portable Digital Color | |||||
| Doppler Ultrasound System is | |||||
| intended for use in environments | |||||
| where healthcare is provided by | |||||
| appropriately trained and qualified | |||||
| healthcare professionals. | abdominal, pediatric, small | ||||
| organ(breast, thyroid, testes), | |||||
| neonatal and adult cephalic, | |||||
| trans-rectal, trans-vaginal, | |||||
| musculo-skeletal(conventional, | |||||
| superficial), adult and pediatric | |||||
| cardiac, peripheral vessel and | |||||
| urology exams. | Musculo-skeletal (Conventional); | ||||
| Musculo-skeletal (Superficial); | |||||
| Peripheral Vascular (PV); and | |||||
| Urology (including prostate). | modes. It is indicated for | ||||
| diagnostic ultrasound imaging and | |||||
| fluid flow analysis in the | |||||
| following applications: Pediatrics, | |||||
| Small Organ, Musculoskeletal, | |||||
| Peripheral Vessel, Carotid. | |||||
| The Digital Color Doppler Palm | |||||
| Ultrasound System is intended for | |||||
| use in environments where | |||||
| healthcare is provided by | |||||
| healthcare professionals. | |||||
| Type of use | Prescription Use | Prescription Use | Prescription Use | Prescription Use | Same |
| Operation Mode | B (2D) mode | ||||
| Color Doppler mode | |||||
| Pulsed Wave mode | B-Mode, M-Mode, PW-Mode, | ||||
| CW-Mode, Color-Mode, | |||||
| Power/Dirpower Mode, THI or the | |||||
| combined mode (B/M-Mode, | |||||
| B/PW-mode, B/PW/Color) | B mode | ||||
| M mode | |||||
| PWD mode | |||||
| Color Doppler | |||||
| Power Doppler | |||||
| Tissue Harmonic Imaging | |||||
| Combined (B/Color Doppler, | |||||
| B/PWD, B/Color Doppler/PWD) | B (2D) mode | ||||
| B/M mode | |||||
| Color Doppler mode | |||||
| Combined (B+Color)mode | |||||
| Pulsed Wave mode | |||||
| Fusion Harmonic Imaging modes | Similar | ||||
| Application area | Abdominal | ||||
| Small Organ | |||||
| Musculoskeletal | |||||
| Peripheral Vessel | |||||
| Carotid | Fetal, abdominal, pediatric, small | ||||
| organ, neonatal and adult cephalic, | |||||
| trans-rectal, trans-vaginal, | |||||
| musculo-skeletal (conventional, | |||||
| superficial), adult and pediatric | Fetal | ||||
| Abdominal | |||||
| Pediatric | |||||
| Small Organ | |||||
| Musculo-skeletal | Pediatrics | ||||
| Small Organ | |||||
| Musculoskeletal | |||||
| Peripheral Vessel | |||||
| Carotid | Similar | ||||
| Urology | cardiac, peripheral vessel and | ||||
| urology | Peripheral Vascular (PV) | ||||
| Urology | |||||
| Transducer Types | Linear array | ||||
| Convex Array | Linear array | ||||
| Convex Array | Linear array | ||||
| Convex Array | Linear array | Same | |||
| Intended user | Healthcare professionals | Healthcare professionals | Healthcare professionals | Healthcare professionals | Same |
| Applied | |||||
| environment | Environments where healthcare is | ||||
| provided by healthcare | |||||
| professionals | Environments where healthcare is | ||||
| provided by healthcare | |||||
| professionals | Environments where healthcare is | ||||
| provided by healthcare | |||||
| professionals | Environments where healthcare is | ||||
| provided by healthcare | |||||
| professionals | Same | ||||
| Acoustic Output | |||||
| Track | Track 3 | Track 3 | Track 3 | Track 3 | Same |
| Measurements | B (2D) mode: Distance, Trace, | ||||
| Depth, Angle, Circumference, | |||||
| Area | |||||
| Doppler mode: Velocity | 2D mode: Distance, Area, Angle, | ||||
| Volume, Trace Area, | |||||
| Circumference, Heart Rate, | |||||
| Volume | |||||
| Doppler mode: Velocity, Time | 2D mode: Distance, Ellipse, | ||||
| Trace, %Stenosis, Volume | |||||
| M mode: Distance, | |||||
| Time, %Stenosis | |||||
| Doppler mode: Velocity, Time | 2D mode: Depth, Distance, Area, | ||||
| Volume | |||||
| Doppler mode: D Velocity, Time | |||||
| B/M mode: Distance, Time, HR | Similar | ||||
| Design | Handheld | Floor Standing | Handheld | Handheld | Similar |
| Power supply | DC 5V | 100-127V ~ or 220-240 V ~ | |||
| 50/60Hz | DC 5V | DC 5V | Similar | ||
| Operating | |||||
| environment | Ambient temperature: 5°C ~ 40°C | ||||
| Relative humidity: 30% ~ 85% | |||||
| (No condensation) | |||||
| Atmospheric pressure: 80kPa ~ | |||||
| 106kPa | Temperature: 0°C~40°C | ||||
| Relative humidity: 30%~85% (no | |||||
| condensation) | |||||
| Atmospheric pressure: | |||||
| 700hPa~1060hPa | Temperature: 10-35°C; | ||||
| Relative humidity: 30-75%; | |||||
| Barometric pressure: 700 to 1060 | |||||
| hPa | Temperature: 10-38°C; | ||||
| Relative humidity: 30-75%; | |||||
| Barometric pressure: 700 to 1060 | |||||
| hPa | Similar | ||||
| Transportation & | Ambient temperature: -20°C ~ | Temperature: -20°C~55°C | Temperature: -25-60°C; | Temperature: -10-50°C; | |
| Storage | |||||
| environment | Relative humidity: 20%~95% (no | ||||
| condensation) | |||||
| Atmospheric pressure: | |||||
| 700hPa~1060hPa | Relative humidity: 20-90% | ||||
| Barometric pressure: 700 to 1060 | |||||
| hPa | Relative humidity: ≤80%, | ||||
| non-condensing; | |||||
| Barometric pressure: 700 to 1060 | |||||
| hPa | |||||
| 55°C | |||||
| Relative humidity: 15% ~ 95% | |||||
| (No condensation) | |||||
| Atmospheric pressure: 80kPa ~ | |||||
| 106kPa | |||||
| Weight | SCN201D: 500g | ||||
| SCN201L: 450g |